The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with severe aplastic anemia (SAA). New research ...

Found in Some People With Long-Term Conditions That Involve Inflammation Medically reviewed by Gagandeep Brar, MD Anemia of chronic disease is a type of anemia caused by inflammation from long-term ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on aplastic anemia, day in and day out. A handful of people form the core of your care team. You have an physician ...

On the surface, Owen Ho looked fine. But on the inside, it was a different story. Ho, 42, was exhausted. He couldn’t muster up the strength to exercise even though months earlier, six-hour bike rides ...

Once they started noticing the bruises and bloody nose that just wouldn't stop, parents Khloe and Adam Haney knew something was wrong with little 2-year-old Karina. "That's when the fatigue started, ...

Please provide your email address to receive an email when new articles are posted on . Outcomes after haploidentical transplant for severe aplastic anemia have improved significantly with use of post ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

A new study from the U.K. examined COVID-19 vaccine efficacy among 175 patients with aplastic anemia and PNH. After a first vaccination, healthy volunteers had a seroconversion rate of 95%, compared ...